期刊文献+

孟鲁司特对毛细支气管炎患儿尿白三烯E4水平的影响 被引量:3

Effect of montelukast on the level of urine leukotriene E4 in children with bronchiolitis
下载PDF
导出
摘要 目的:观察孟鲁司特对毛细支气管炎患儿尿白三烯E4(LTE4)水平的影响。方法:将69例急性期毛支患儿随机分为孟鲁司特治疗组和常规治疗组,对两组进行疗效比较及尿LTE4测定;同时对48例缓解期毛支分别予孟鲁司特和丙酸氟替卡松吸入,1个月后观察两组的尿LTE4水平变化。结果:孟鲁司特组气急消失时间、体征消失时间和住院时间均较常规组缩短(P<0.01)。毛支治疗前,孟鲁司特组和常规组尿LTE4水平比较无统计学差异(P>0.05),与对照组比较,两者均明显升高(P<0.01);治疗后,孟鲁司特组尿LTE4水平较常规组明显下降,差异有统计学意义(P<0.01),与对照组比较无统计学意义(P>0.05);而常规组尿LTE4水平仍高于对照组(P<0.01)。毛支缓解后,分别予孟鲁司特和丙酸氟替卡松吸入治疗1个月,后孟鲁司特组尿LTE4水平明显低于激素吸入组。结论:孟鲁司特可有效降低毛支患儿急性期及缓解期尿LTE4水平,改善毛支患儿的临床症状。 AIM: To observe the effects of montelukast on the level of urine LTE4 in children with bronchiolitis.METHODS: Sixty-nine cases of children with bronchiolitis were divided into two groups randomly,a group with montelukast treatment and a group with regular treatment.The treatment effects and the urine LTE 4 level of the two groups were compared.At the same time,48 cases of children with bronchiolitis in remission were given montelukast or fluticason inhalation,the changes of level on urine LTE4 of the two groups were observed.RESULTS:The period to the disappearance of breath shortness,the disappearance of physical symptoms and the length of stay in hospital of montelukast group were shorter than those in the group with regular treatment(P0.01).Before the therapy,there was no significant difference of urine LTE4 between the groups of montelukast treatment and regular treatment(P0.05),the level of urine LTE4 in both group were increased compared with the control group(P0.01).After therapy,the urine LTE4 level of the montelukast treatment group was decreased obviously compared with those of the regular treatment group(P0.01).There was no significant difference compared with the comparison group(P0.05);while the urine LTE4 level of group with regular treatment was higher than those of control group(P0.01).After the remission of bronchiolitis,the children were given with montelukast or fluticasone propionate inhalation for a month and there was obviously lower level urine LTE4 in the group montelukast treatment than the group with hormone treatment.CONCLUSION: Montelukast can effectively decrease the levels of urine LTE4 in the acute phrase and remission and improve the clinical symptoms of children with bronchiolitis.
出处 《中国临床药理学与治疗学》 CAS CSCD 2012年第4期441-444,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 孟鲁司特 毛细支气管炎 半胱氨酰白三烯 Montelukast Bronchiolitis Cysteinyl leukotriene
  • 相关文献

参考文献9

  • 1Bizzintino JA, Khoo SK, Zhang G, et al. Leukot riene pathway polymorphisms are associated with altered cysteinyl leukotriene production in children with acute asthma[J]. Prostaglandins Leukot EssentFatty Acids, 2009,81(1) :9--15.
  • 2姚欢银,刘淑梅,朱国政,陈啸洪,谢科杰,楼文勇,王伟,王小仙.毛细支气管炎患儿尿白三烯E4检测及其意义[J].临床儿科杂志,2010,28(2):152-155. 被引量:20
  • 3胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:632-636.
  • 4Bacharier LB. Viral-induced wheezing episodes in preschool children., approaches to therapy[J]. Curr Opin Pulm Med, 2010 ,16(1) :31--35.
  • 5Rubin P, Mollison KW. Pharmaeotherapy of diseases mediated by 5-1ipoxygcnase pathway eicosanoids [J]. Prostaglandins Other Lipid Mediat, 2007, 83 (3) :188--197.
  • 6Rabinovitch N, Graber NJ, Chinchilli VM, et al. Urinary leukotriene E4/exhaled nitric oxide ratioand montelukast response in childhood asthma[J]. J Allergy Clin Immunol, 2010,126 ( 3 ) : 545 -- 551.
  • 7Bisgaard H, Flores-Nunez A, Goh A, et al. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bron- chiolitis in children[J]. Am J Respir Crit Care Med, 2008,178(8) :854--860.
  • 8胡爱娟.孟鲁司特治疗呼吸道合胞病毒毛细支气管炎的疗效观察[J].中国医药导报,2010,7(24):58-59. 被引量:5
  • 9Fal AM, Kopec A. Status of leukotrienes in the pathophysiology of asthma. Necessity for antileu- kotrienes treatment [J ]. Pneumonol Alergol Pol, 2010,78(1) :68--73.

二级参考文献28

  • 1曹霞,蔡畅,杨炯,郭卫,胡苏萍.哮喘患者白三烯代谢与孟鲁司特疗效的研究[J].武汉大学学报(医学版),2006,27(3):342-345. 被引量:9
  • 2Welliver RC. Immunologic mechanisms of virus-induced wheezing and asthma [J]. J Pediatr, 1999, 135(2 Pt 2):14-20.
  • 3Green SA, Malice MP, Tanaka W, et al. Increase in urinary leukotriene LTE4 levels in acute asthma: cor- relation with airflow limitation [J]. Thorax,2004,59(2) : 100-104.
  • 4Aberle JH, Aberle SW, Dworzak MN, et ol. Reduced interferon-γ expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease [J]. Am J Respir Crit Care Med, 1999,160(4) : 1263-1268.
  • 5刘春涛.白三烯与气道炎症[M]//刘春涛,王曾礼.气道炎症性疾病.北京:人民卫生出版社,2004:329-364.
  • 6Smith CM, Hawksworth R J, Thien FC, et al. Urinary leukotriene E4 in bronchial asthma [J]. Eur Respir J, 1992,5 (6) : 693-699.
  • 7Wennergren G. Inflammatory mediators in blood and urine [J ]. Paediatr Respir Rev,2000, 1 (3) :259-265.
  • 8Gentile DA, Fireman P, Skoner DP. Elevations of local leukotriene C4 levels during viral upper respiratory tract infections [J]. Ann Allergy Asthma Immunol,2003,91 (3) :270-274.
  • 9Da Dalt L, Callegaro S, Carraro S, et al. Nasal lavage leukotrienes in infants with RSV bronchiolitis [J ]. Pediatr Allergy Immunol,2007,18(2) :100-104.
  • 10Takahashi Y, Ichikawa M, Nawate M, et al. Clinical evaluation of urinary leukotriene E4 levels in children with respiratory syncytial virus infection [J]. Arerugi, 2003,52 (12) : 1132-1137 [Japanese ].

共引文献1932

同被引文献15

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部